ANGPT |
Angiopoietin |
ARG1 |
Arginase 1 |
CAFs |
Cancer-associated fibroblasts |
CSC |
Cancer stem cell |
CSF |
Colony stimulating factor |
CTLA-4 |
Cytotoxic T-lymphocyte-associated protein 4 |
ECM |
Extracellular matrix |
EGF |
Epidermal growth factor |
EMT |
Epithelial-to-mesenchymal transition |
EPR |
Enhanced permeability and retention |
FAP |
Fibroblast activation protein |
FGF |
Fibroblast growth factor |
FRβ |
Targeted-folate-receptor beta |
GM-CSF |
Granulocyte-macrophage colony stimulating factor |
HGF |
Hepatocyte growth factor |
HIF-1 |
Hypoxia-induced factor-1 |
IL |
Interleukin |
IFN |
Interferon |
iNOS |
Inducible nitric oxide synthase |
MCTS |
Multicellular tumor spheroids |
MDR |
Multidrug resistance |
MDSCs |
Myeloid-derived suppressive cells |
MMPs |
Matrix metalloproteinases |
MT |
Malignant transition |
NSCLC |
Non-small cell lung cancer |
NK |
Natural killer |
NKT |
Natural killer T |
PD-1 |
Programmed death 1 receptor |
PDMS |
Polymethylsiloxane |
PlGF |
Placental growth factor |
PDGF |
Platelet-derived growth factor |
PHD-2 |
Prolyl-hydroxylase enzyme-2 |
TAM |
Tumor-associated macrophage |
TCDEs |
Tumor cells derived exosomes |
TME |
Tumor microenvironment |
TGF |
Transforming growth factor |
TNF |
Tumor necrosis factor |
Treg |
Regulatory T cells |
VEGF |
Vascular endothelial growth factor |